Tajima K, Yamamoto K, Mizutani T
Biochem Pharmacol. 1985 Jun 15;34(12):2109-14. doi: 10.1016/0006-2952(85)90403-4.
Butylated hydroxytoluene (BHT) was converted to S-(3,5-di-tert-butyl-4-hydroxybenzyl)-glutathione (BHT-glutathione) by rat liver microsomes in the presence of NADPH, molecular oxygen, and glutathione. NADH was far less effective than NADPH and exhibited little synergistic effect when used together with NADPH. Cytochrome P-450 inhibitors, such as SKF 525-A, alpha-naphthoflavone, metyrapone, and carbon monoxide, significantly inhibited BHT-glutathione formation. Liver microsomes from phenobarbital-treated rats catalyzed the formation of BHT-glutathione at a rate that was nine times the rate of adduct formation by control microsomes. No stimulation of BHT-glutathione formation was observed with the addition of liver cytosol fraction to the microsomal incubation mixtures even at low glutathione concentrations. These results support the view that BHT is converted by the cytochrome P-450 monooxygenases to a chemically reactive metabolite, possibly BHT-quinone methide, which forms BHT-glutathione by nonenzymatic conjugation with glutathione.
在存在烟酰胺腺嘌呤二核苷酸磷酸(NADPH)、分子氧和谷胱甘肽的情况下,大鼠肝脏微粒体将丁基化羟基甲苯(BHT)转化为S-(3,5-二叔丁基-4-羟基苄基)-谷胱甘肽(BHT-谷胱甘肽)。烟酰胺腺嘌呤二核苷酸(NADH)的效果远不如NADPH,并且与NADPH一起使用时几乎没有协同作用。细胞色素P-450抑制剂,如SKF 525-A、α-萘黄酮、美替拉酮和一氧化碳,显著抑制BHT-谷胱甘肽的形成。苯巴比妥处理的大鼠的肝脏微粒体催化BHT-谷胱甘肽形成的速率是对照微粒体形成加合物速率的九倍。即使在低谷胱甘肽浓度下,向微粒体孵育混合物中添加肝脏胞质溶胶部分也未观察到对BHT-谷胱甘肽形成的刺激作用。这些结果支持这样一种观点,即BHT被细胞色素P-450单加氧酶转化为一种化学反应性代谢物,可能是BHT-醌甲基化物,它通过与谷胱甘肽的非酶结合形成BHT-谷胱甘肽。